Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. logos of OpenAI There’s interesting news coming from Sam Altman’s empire, a firm known for ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

May 22, 2026 Scientists have uncovered a strange hidden structure formed during the creation of metallocenes, a class of sandwich-like molecules used in everything from catalysis to medicine. The ...

Ashlyn is one of Forbes Home's in-house writers and a former civil engineer-turned content writer with over six years experience. Until recently, Ashlyn focused on creating content for Forbes Home as ...

Despite hundreds of altcoins competing for attention, Bitcoin (BTC) and Ethereum (ETH) continue to dominate the cryptocurrency market in 2026. Combined, these two assets represent about 70% of total ...

Katherine Gallagher is a writer and sustainability expert. She holds a B.A. in English Literature from Chapman University and a Sustainable Tourism certificate from the GSTC. The difference between ...

Call options grant the right to buy stocks at a set price until expiration; puts allow selling. Options expire worthless if stock doesn't reach breakeven, risking the premium paid. Selling options can ...

Thrombosis and embolism are both blood clots that reduce or block blood flow inside your blood vessels. They’re two different yet serious conditions. Here’s a look at the differences and similarities.

Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Stella Osoba is the Senior Editor of ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...